nach oben

Indian Journal of Surgical Oncology

Erschienen in:

17.02.2022 | Original Article

Spectrum of Germ Cell Tumor (GCT): 5 Years’ Experience in a Tertiary Care Center and Utility of OCT4 as a Diagnostic Adjunct

verfasst von: Paul Paramita, Agarwal Preeti, Jain Mili, Jaiswal Ridhi, Sagar Mala, Goel MM

Erschienen in: Indian Journal of Surgical Oncology | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Germ cell tumors (GCT) are an intriguing group of neoplasm having myriad clinical and morphological presentation. More and more transcription factors are being evaluated for identification of same. To study the spectrum of GCTs in a tertiary care center and the use of a stem cell marker OCT4 as a diagnostic adjunct, a retrospective 5-year (2008–2013) study was carried out. Immunohistochemistry (IHC) with OCT4 was performed on all cases and IHC for α feto protein (AFP), CD30, and epithelial membrane antigen (EMA) as per requirement. Cohort included 73 cases (23 males and 50 females). Testicular and ovarian GCTs accounted for 95.83% and 35.71% respectively. In males, seminoma was the commonest (34.78%) followed by mixed GCT (26%). 17.85% of ovarian GCTs were malignant mostly constituted by dysgerminoma (18%). Benign mature cystic teratoma (MCT) constituted 50% of ovarian GCTs. OCT4 immunoexpression was seen in all cases of seminoma/dysgerminoma, embryonal carcinoma, immature teratoma, and seminomatous/embryomatous component of mixed GCTs. Pure yolk sac tumor (YST) and MCT were consistently negative. OCT4 was especially helpful in identification of mixed GCT. A panel of immunohistochemical markers would be a more ideal way to identify and clarify the components because correct identification of the components is important for therapeutic intervention and prognostication. OCT4 being a primordial germ cell marker predicts aggressive behavior and targeted therapy against this should be investigated.

Pierce GB (1967) Teratocarcinoma: model for a developmental concept of cancer. Curr Top Dev Biol 2:223–246. https://doi.org/10.1016/s0070-2153(08)60289-6CrossRefPubMed

Anderson R, Copeland TK, Schöler H, Heasman J, Wylie C (2000) The onset of germ cell migration in the mouse embryo. Mech Dev 91(1–2):61–68. https://doi.org/10.1016/s0925-4773(99)00271-3CrossRefPubMed

Cheng L, Sung MT, Cossu-Rocca P, Jones TD, MacLennan GT, De Jong J, Lopez-Beltran A, Montironi R, Looijenga LH (2007) OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol 211(1):1–9. https://doi.org/10.1002/path.2105CrossRefPubMed

Gershenson DM (2007) Management of ovarian germ cell tumors. J Clin Oncol 25(20):2938–2943. https://doi.org/10.1200/JCO.2007.10.8738CrossRefPubMed

Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H, Honecker F, Bokemeyer C, Perlman EJ, Schneider DT, Kononen J, Sauter G, Oosterhuis JW (2003) POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63(9):2244–2250PubMed

Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Schöler H, Smith A (1998) Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell. 95(3):379–91. https://doi.org/10.1016/s0092-8674(00)81769-9CrossRefPubMed

Berney DM, Looijenga LH, Idrees M, Oosterhuis JW, Rajpert-De Meyts E, Ulbright TM, Skakkebaek NE (2016) Germ cell neoplasia in situ (GCNIS): evolution of the current nomenclature for testicular pre-invasive germ cell malignancy. Histopathology 69(1):7–10. https://doi.org/10.1111/his.12958CrossRefPubMed

Nogales FF, Dulcey I, Preda O (2014) Germ cell tumors of the ovary: an update. Arch Pathol Lab Med 138(3):351–362. https://doi.org/10.5858/arpa.2012-0547-RACrossRefPubMed

Sankaranarayanan R, Ferlay J (2006) Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 20(2):207–225. https://doi.org/10.1016/j.bpobgyn.2005.10.007CrossRefPubMed

10.

Mankar DV, Jain GK (2015) Histopathological profile of ovarian tumours: a twelve year institutional experience. Muller J Med Sci Res 6:107–111CrossRef

11.

Bosl GJ, Motzer RJ (1997) Testicular germ-cell cancer. N Engl J Med 337(4):242–253. https://doi.org/10.1056/NEJM199707243370406CrossRefPubMed

12.

Bhattacharyya NK, De A, Bera P, Sristidhar M, Chakraborty S, Bandopadhyay R (2010) Ovarian tumors in pediatric age group - a clinicopathologic study of 10 years’ cases in West Bengal. India Indian J Med Paediatr Oncol 31(2):54–57. https://doi.org/10.4103/0971-5851.71656CrossRefPubMed

13.

Atlasi Y, Mowla SJ, Ziaee SAM, Bahrami A-R (2007) OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer 120:1598–1602CrossRef

14.

Wu YC, Ling TY, Lu SH, Kuo HC, Ho HN, Yeh SD, Shen CN, Huang YH (2012) Chemotherapeutic sensitivity of testicular germ cell tumors under hypoxic conditions is negatively regulated by SENP1-controlled sumoylation of OCT4. Cancer Res 72(19):4963–4973. https://doi.org/10.1158/0008-5472.CAN-12-0673CrossRefPubMed

15.

Lakshmanan M, Gupta S, Kumar V, Akhtar N, Chaturvedi A, Misra S, Jain K, Garg S (2018) Germ cell tumor ovary: an institutional experience of treatment and survival outcomes. Indian J Surg Oncol 9(2):215–219. https://doi.org/10.1007/s13193-018-0742-xCrossRefPubMedPubMedCentral

16.

Joshi A, Zanwar S, Shetty N, Patil V, Noronha V, Bakshi G et al (2016) Epidemiology of male seminomatous and nonseminomatous germ cell tumors and response to first-line chemotherapy from a tertiary cancer center in India. Indian J Cancer 53:313–316. https://doi.org/10.4103/0019-509X.197741CrossRefPubMed

17.

Ulbright TM (2005) Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol 18(Suppl 2):S61-79. https://doi.org/10.1038/modpathol.3800310CrossRefPubMed

18.

Cheng L (2004) Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry. Cancer 101(9):2006–2010. https://doi.org/10.1002/cncr.20566CrossRefPubMed

19.

Sung MT, Jones TD, Beck SD, Foster RS, Cheng L (2006) OCT4 is superior to CD30 in the diagnosis of metastatic embryonal carcinomas after chemotherapy. Hum Pathol 37(6):662–667. https://doi.org/10.1016/j.humpath.2006.01.019CrossRefPubMed

20.

Talerman, Aleksander, and Russell Vang. Blaustein’s pathology of the female genital tract. 6th ed., Springer, 2011.Chapter 16 ,Germ cell tumor. P 848–897. https://doi.org/10.1007/978-1-4419-0489-8

21.

Sung MT, Jones TD, Beck SD Foster RR, Cheng L ( 2006) OCT3/4 is superior to CD30 in the diagnosis of metastatic EC after chemotherapy. Hum Pathol 37(6) 662–7

22.

McKenney JK, Heerema-McKenney A, Rouse RV (2007) Extragonadal germ cell tumors: a review with emphasis on pathologic features, clinical prognostic variables, and differential diagnostic considerations. Adv AnatPathol 14(2):69–92. https://doi.org/10.1097/PAP.0b013e31803240e6CrossRef

23.

Baker PM, Oliva E (2005) Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update. Int J GynecolPathol 24(1):39–55

24.

Ismail S. Mohiuddin, Sung-Jen Wei, Min H. Kang (2020) Role of OCT4 in cancer stem-like cells and chemotherapy resistance. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866(4) 165432 https://doi.org/10.1016/j.bbadis.2019.03.005.

25.

Rajeswari B, Nair M, Ninan A, Parukuttyamma K (2016) Ovarian tumors in children: 10-year experience from a tertiary care center in South India. Indian J Cancer 53:292–295. https://doi.org/10.4103/0019-509X.197726CrossRefPubMed

26.

Hemanth Kumar, S.V. Saju, Venkatraman Radhakrishnan, Anand Raja, Trivadi S ( 2020) Ganesan, Manikandan Dhanushkodi et al. Analysis of extra-cranial germ cell tumors in male children: experience from a single centre in India. Pediatr Hematol Oncol J 5(2):37–42. https://doi.org/10.1016/j.phoj.2020.03.012

27.

Shen H, Shih J, Hollern DP, Wang L, Bowlby R, Tickoo SK et al (2018) Integrated molecular characterization of testicular germ cell tumors. Cell Rep 23(11):3392–3406. https://doi.org/10.1016/j.celrep.2018.05.039CrossRefPubMedPubMedCentral

28.

Biermann K, Göke F, Nettersheim D, Eckert D, Zhou H, Kahl P, Gashaw I, Schorle H, Büttner R (2007) c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma. J Pathol 213(3):311–318. https://doi.org/10.1002/path.2225CrossRefPubMed

29.

Looijenga LH, de Leeuw H, van Oorschot M, van Gurp RJ, Stoop H, Gillis AJ et al (2003) Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors. Cancer Res 63(22):7674–7678PubMed

30.

Gilbert D, Rapley E, Shipley J (2011) Testicular germ cell tumours: predisposition genes and the male germ cell niche. Nat Rev Cancer 11(4):278–288. https://doi.org/10.1038/nrc3021CrossRefPubMed

31.

Isabella Syring, Joanna Bartels, Stefan Holdenrieder, Glen Kristiansen, Stefan C. Müller, Jörg Ellinger (2015) Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer, The Journal of Urology 193(1) 331-7, ISSN 0022-5347. https://doi.org/10.1016/j.juro.2014.07.010

32.

Albany C, Hever-Jardine M. P, von Herrmann K. M, Yim C. Y, Tam J, Warzecha J. M et al. (2017) Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine. Oncotarget. 8: 2949–59.https://doi.org/10.18632/oncotarget.13811

33.

Cavallo F, Graziani G, Antinozzi C, Feldman DR, Houldsworth J, Bosl GJ et al (2012) Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to cisplatin and poly (ADP-ribose) polymerase inhibition. PLoS ONE 7(12):e51563. https://doi.org/10.1371/journal.pone.0051563CrossRefPubMedPubMedCentral

34.

Fernández-Cabezudo MJ, Faour I, Jones K, Champagne DP, Jaloudi MA, Mohamed YA, Bashir G et al (2016) Deficiency of mitochondrial modulator MCJ promotes chemoresistance in breast cancer. JCI Insight 1(7):e86873. https://doi.org/10.1172/jci.insight.86873CrossRefPubMedPubMedCentral

35.

Faulkner SW, Friedlander ML (2000) Microsatellite instability in germ cell tumors of the testis and ovary. Gynecol Oncol 79(1):38–43. https://doi.org/10.1006/gyno.2000.5906.

36.

King BL, Carcangiu ML, Carter D, et al (1995) Microsatellite instability in ovarian neoplasms. Br J Cancer. 1995;72: 376 –382 King, B., Carcangiu, ML., Carter, D. et al. Microsatellite instability in ovarian neoplasms. Br J Cancer 72 376–382. https://doi.org/10.1038/bjc.1995.341

37.

JorgensenN,Muller J, Jaubert F, Clausen OP, Skakkebaek NE (1997) Heterogeneity of gonadoblastoma germ cells: similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells. Histopathology. 30: 177–86. https://doi.org/10.1046/j.1365-2559.1997.d01-580.x

38.

Cools M, Looijenga LH, Wolffenbuttel KP, Drop SL (2009) Disorders of sex development: update on the genetic background, terminology and risk for the development of germ cell tumors. World J Pediatr 5(2):93–102. https://doi.org/10.1007/s12519-009-0020-7CrossRefPubMed

Titel: Spectrum of Germ Cell Tumor (GCT): 5 Years’ Experience in a Tertiary Care Center and Utility of OCT4 as a Diagnostic Adjunct
verfasst von: Paul Paramita
Agarwal Preeti
Jain Mili
Jaiswal Ridhi
Sagar Mala
Goel MM
Publikationsdatum: 17.02.2022
Verlag: Springer India
Erschienen in: Indian Journal of Surgical Oncology / Ausgabe 3/2022
Print ISSN: 0975-7651
Elektronische ISSN: 0976-6952
DOI: https://doi.org/10.1007/s13193-022-01522-w

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2022

Impact of Morbid Obesity on the Outcomes of Type II Endometrial Cancer: a Cohort Study

Serum MicroRNA 21 and Tumour Marker in Oesophagus Cancer: Correspondence

Correlation Of Bi-Rads 4 Subcategories Breast Lesions On Tomosynthesis And Histopathological Examination With P63 Immunohistochemistry Expression

Parietal Peritoneal Flap for Post-radiation Bladder Injury Repair

Outcome of Postoperative Facial Nerve Function Following Electromyographic Facial Nerve Monitoring During Parotidectomy for Benign Lesions: a Retrospective Study

Advanced Autologous Lower Dermal Sling Technique for Immediate Breast Reconstruction Surgery in Small and Non-ptotic Breasts

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Hinter dieser Appendizitis steckte ein Erreger

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“